Windtree Therapeutics (WINT) Financials

$0.00

$0.00 (200.00%)

As on 04-Sep-2026 09:59EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.09	--	--	--	--	--
Cost of Revenue	0.39	0.08	0.08	1.06	0.87	0.64
Gross Profit	-0.39	-0.08	-0.08	-1.06	-0.87	-0.64
Operating Expenses	32.38	24.94	17.46	20.43	31.39	30.32
Operating Profit (EBIT)	-32.38	-25.02	-17.54	-41.33	-77.28	-30.32
Other Income	--	--	--	--	--	-2.12
Profit before Tax	-43.50	-1.79	-20.29	-40.58	-77.62	-32.57
Provision for Tax	0.78	3.69	-0.09	-1.37	-9.99	-2.29
Profit after Tax (Net Income)	-40.00	-5.49	-20.29	-39.21	-67.64	-30.28
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-67.64	-32.57

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-11.61	10.00	3.39	10.01	41.88	69.55
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.68	12.16	25.02	25.49	27.99	37.20
Current Liabilities	21.90	5.72	4.00	2.46	4.92	6.13
Total Liabilities	37.88	27.88	32.41	37.95	74.79	112.89

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	8.78	25.30	27.03	30.58	51.30	94.77
Current Assets	7.21	2.57	5.38	7.38	23.49	18.12
Total Assets	37.88	27.88	32.41	37.95	74.79	112.89
Total Debt*	12.93	1.82	16.83	2.28	2.89	3.78
Net Current Assets	-14.70	-3.14	1.38	4.92	18.57	11.99

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-15.40	-13.44	-19.45	-23.66	-25.32
Cash Flow from Investing Activities	--	-0.01	-0.02	0.20	-0.28	-0.29
Cash from Financing Activities	--	12.73	11.60	3.08	29.36	19.96
Net Cash Inflow / Outflow	--	--	--	--	--	-5.65

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-3,583.61	-21.40	-3,028.51	-43,564.44	-25.33	-17.11
Cash EPS ($)	--	-21.07	-3,016.27	-42,972.22	-25.26	-17.02
Adjusted Book Value ($)	--	38.99	506.12	11,124.44	15.68	39.31
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-60.07	-2,005.52	-21,613.33	-8.86	-14.31
Free Cash Flow per Share ($)	--	-60.12	-2,007.76	-21,627.78	-8.97	-14.47

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-34.25	-124.82	-137.41	-114.53	-35.88
ROE (%)	--	-81.98	-302.78	-151.11	-121.39	-41.91
ROA (%)	-96.67	-18.20	-57.68	-69.55	-72.08	-26.12
EBIT Margin (%)	-55,762.22	--	--	--	--	--
Net Margin (%)	-44,447.78	--	--	--	--	1,425.61
Cash Profit Margin (%)	-0.44	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	--	--	--	--	-1.00
EBIT Growth (%)	-431.01	92.30	50.05	47.72	-138.92	-20.24
Net Profit Growth (%)	-312.06	72.96	48.25	42.03	-123.37	-10.21
EPS Growth (%)	-311.29	0.99	0.93	-1,719.01	-0.48	0.28
Book Value Growth (%)	-274.56	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.02	0.00	0.00	-0.06	-0.30
Price / Book Value	0.61	0.01	0.00	0.00	0.10	0.13
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.01	-0.09	-0.62	0.10	0.20	0.13
Close Price ($)	0.08	17.47	36.00	425.00	4,012.49	12,824.93
High Price ($)	115.50	737.44	952.75	4,299.95	15,824.68	33,374.63
Low Price ($)	0.06	13.27	33.50	375.12	3,452.30	10,000.00
Market Cap ($ Cr)	0.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.18	4.96	0.23	0.07	0.05
Short term debt to equity ratio	-1.09	0.12	0.20	0.07	0.02	0.02
Current Ratio	0.33	0.45	1.35	3.00	4.77	2.96
Quick Ratio	0.33	--	--	--	--	--
Interest Coverage	-88.14	-6.63	-404.82	-764.57	-679.90	-259.53

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	6,447.78	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	5,844.00	2,356.31	162.14	389.63	821.24
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.